REGN
Regeneron Pharmaceuticals Inc
Price:
570.59
USD
Volume:
717,051
United States | Biotechnology
Regeneron Current Ratio
As of 2025-07-15, the Current Ratio of Regeneron Pharmaceuticals Inc (REGN) is 4.73.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
Regeneron Current Ratio - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | 4.73 |
| 2023-12-31 | 5.69 |
| 2022-12-31 | 5.06 |
| 2021-12-31 | 3.56 |
| 2020-12-31 | 3.63 |
| 2019-12-31 | 3.67 |
| 2018-12-31 | 4.47 |
| 2017-12-31 | 3.82 |
| 2016-12-31 | 2.56 |
| 2015-12-31 | 3.59 |
Regeneron Current Ratio - Peers Comparison